The introduction of Retatrutide ZPHC, at a strength of 120mg, is generating considerable buzz within the weight loss community. This novel dual GIP and GLP-1 agonist medication appears to provide impressive improvements in body loss compared to previous therapies. Initial patient trials have demo… Read More